首页> 美国卫生研究院文献>other >Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis

【2h】

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis

机译：非维生素K拮抗剂口服抗凝剂和维生素K拮抗剂口服抗凝剂在房颤射频导管消融患者中的疗效和安全性：一项荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundUse of the non-vitamin K antagonist oral anticoagulants (NOACs) is endorsed by current guidelines for stroke prevention in patients with atrial fibrillation (AF). However efficacy and safety of NOACs in patients undergoing catheter ablation (RFCA) of AF has not been well established yet.

机译：背景技术目前，房颤（AF）患者的中风预防指南已批准使用非维生素K拮抗剂口服抗凝剂（NOAC）。但是，尚未成功确定NOAC在接受AF导管消融（RFCA）的患者中的疗效和安全性。

著录项

期刊名称 other
作者
Giuseppe Santarpia; Salvatore De Rosa; Alberto Polimeni; Salvatore Giampà; Mariella Micieli; Antonio Curcio; Ciro Indolfi;
展开▼
作者单位

展开▼
年(卷),期 -1(10),5
年度 -1
页码 e0126512
总页数 18
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Meta-Analysis of Safety and Efficacy of Uninterrupted Non–Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation [J] . Akram Y. Elgendy, Dhruv Mahtta, Amr F. Barakat, The American Journal of Cardiology . 2017,第10期

机译：荟萃分析不间断的非维生素K拮抗剂口腔抗凝血剂与维生素K拮抗剂的安全性和疗效分析，用于对心房颤动的导管消融
2. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation [J] . Wu Shuang, Yang Yan-min, Zhu Jun, The American Journal of Cardiology . 2016,第6期

机译：房颤消融行导管消融术中新型口服抗凝剂和不间断维生素K拮抗剂的疗效和安全性的荟萃分析
3. Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban [J] . Iwona Gorczyca, Magdalena Chrapek, Olga Jelonek, Cardiology research and practice . 2020,第1期

机译：左心房阑尾血栓形成尽管持续的非维生素K拮抗剂口腔抗凝血剂治疗，心房颤动患者接受电气心致或导管消融：Dabigatran和Rivaroxaban的比较
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
6. Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation [O] . Hirosuke Yamaji, Takashi Murakami, Kazuyoshi Hina, -1

机译：消融导管消融治疗房颤患者非维生素K拮抗剂口服抗凝剂的安全性和有效性
7. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis. [O] . Giuseppe Santarpia, Salvatore De Rosa, Alberto Polimeni, 2015

机译：非维生素K拮抗剂口服抗凝剂与维生素K拮抗剂口服抗凝剂在射频导管消融心房颤动患者中的疗效和安全性：meta分析。

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅